Heterochromatin dysregulation in human diseases

Journal of Applied Physiology

Volumn 109, Issue 1, 2010, Pages 232-242

  Hahn, Matthias ^a   Dambacher, Silvia ^a   Schotta, Gunnar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; Epigenetic therapy; Epigenetics; FRDA; FSHD; Heterochromatin

Indexed keywords

ANIMAL; DROSOPHILA; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; FRIEDREICH ATAXIA; GENE SILENCING; GENERAL ASPECTS OF DISEASE; GENETIC EPIGENESIS; GENETICS; HAPPY PUPPET SYNDROME; HETEROCHROMATIN; HUMAN; METABOLISM; MOUSE; NEOPLASM; PRADER WILLI SYNDROME; REVIEW; DISEASES; NEOPLASMS;

ANGELMAN SYNDROME; ANIMALS; DISEASE; DROSOPHILA; EPIGENESIS, GENETIC; FEMALE; FRIEDREICH ATAXIA; GENE SILENCING; HETEROCHROMATIN; HUMANS; MICE; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NEOPLASMS; PRADER-WILLI SYNDROME;

HETEROCHROMATIN;

EID: 77954325930     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00053.2010     Document Type: Review

References (48)

1. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. Whole chromosome instability caused by Bubl insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16: 475-486, 2009.
2. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev 1, Zhao K. High-resolution profiling of histone methylations in the human, genome. Cell 129: 823-837, 2007. (Pubitemid 46802390)
3. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2, Suppl 1: S4-S11, 2005.
4. Bidichandani SI, Ashizawa T, Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 62: 111-121, 1998. (Pubitemid 28093840)
5. Bodega B, Ramirez GD, Grosser F, Cheli S, Brunelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E, Ginelli E. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol 71: 41, 2009.
6. Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 43.1: 96-99, 2004.
7. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA. Oncogeneinduced senescence as an initial barrier in lymphoma development. Nature 436: 660-665, 2005. (Pubitemid 41117262)
8. Buiting K, Lieh C, Cottrell S, Barnicoat A, Horsthemke B. A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum Genet 105: 665-666, 1999. (Pubitemid 30026047)
9. Butler MG. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet 26: 477-486, 2009.
10. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duelos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michèle G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 111: 1423-1427, 1996. (Pubitemid 26089479)
11. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difllippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 296: 922-927, 2002. (Pubitemid 34464900)
12. Chen J, Odenike O, Rowley JD. Leukaemogenesis: more than mutant genes. Nat Rev Cancer 10: 23-36, 2010.
13. Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 20: 483-489, 2005. (Pubitemid 41572304)
14. Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JA, Hewitt JE. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 81: 264-279, 2007. (Pubitemid 47236075)
15. Cossee M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel JL, Koenig M. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci USA 94: 7452-7457, 1997. (Pubitemid 27345336)
16. De Biase I, Chutake YK, Rindler PM, Bidichandani SI. Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription. PLoS One 4: e7914, 2009.
17. Delaval K, Feil R. Epigenetic regulation, of mammalian genomic imprinting. Curr Opin Genet Dev 14: 188-195, 2004. (Pubitemid 38520147)
18. Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335: 1169-1175, 1996. (Pubitemid 26339770)
19. Ebert A, Schotta G, Lein S, Kubicek S, Krauss V, Jenuwein T, Reuter G. Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila. Genes Dev 18: 2973-2983, 2004. (Pubitemid 39602315)
20. El-Maarri O, Buiting K, Peery EG, Kroisel PM, Balaban B, Wagner K, Urman B, Heyd J, Lieh C, Brannan CI, Walter J, Horsthemke B. Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nat Genet 27: 341-344, 2001. (Pubitemid 32201860)
21. Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 59: 554-560, 1996. (Pubitemid 26269033)
22. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. Loss of acetylation at Lys 16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37: 391-400, 2005. (Pubitemid 40490489)
23. Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR, Tupler R. Facioscapulohumeral muscular dystrophy in mice overexposing FRG1. Nature 439: 973-977, 2006. (Pubitemid 43292415)
24. Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110: 339-348, 2002.
25. Glenn CC, Saitoh S, Jong MT, Filbrandt MM, Surti U, Driscoll DJ, Nicholls RD. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet 58: 335-346, 1996. (Pubitemid 26038939)
26. Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, Eguia R, Dean DC, Esteller M, Jenuwein T, Blasco MA. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 1: 420-428, 2005. (Pubitemid 40533133)
27. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, Jeggo PA. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 31: 167-177, 2008. (Pubitemid 352001394)
28. Greene E, Mahishi L, Entezam A, Kumari D, Usdin K. Repeatinduced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res 35: 3383-3390, 2007. (Pubitemid 47073601)
29. Grewal SI, Elgin SC. Transcription and RNA interference in the formation of heterochromatin. Nature 447: 399-406, 2007. (Pubitemid 46816745)
30. Han J, Kim D, Morris KV. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci USA 104: 12422-12427, 2007.
31. Hanel ML, Wuebbles RD, Jones PL. Muscular dystrophy candidate gene ERG1 is critical for muscle development. Dev Dyn 238: 1502-1512, 2009.
32. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104: 589-620, 1981.
33. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV. Promoter targeted small RNAs induce long-term, transcriptional gene silencing in human cells. Nucleic Acids Res 37: 2984-2995, 2009.
34. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2: 551-558, 2006. (Pubitemid 44413238)
35. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom JC, Francis F, Sharpe PT, Hofker M, et al. Analysis of the tandem, repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 3: 1287-1295, 1994. (Pubitemid 24255461)
36. Hines KA, Cryderman DE, Flannery KM, Yang H, Vitalini MW, Hazelrigg T, Mizzen CA, Wallrath LL. Domains of heterochromatin protein 1 required for Drosophila melanogaster heterochromatin spreading. Genetics 182: 967-977, 2009.
37. Ideraabdullah FY, Vigneau S, Bartolomei MS. Genomic imprinting mechanisms in mammals. Mutat Res 641: 77-85, 2008.
38. Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS, Minna JD, Corey DR. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 13: 787-792, 2006. (Pubitemid 44338772)
39. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M. Testing the position-effect variegation, hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 12: 2909-2921, 2003. (Pubitemid 37442019)
40. Kantor B, Kaufman Y, Makedonski K, Razin A, Shemer R. Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryo. Hum Mol Genet 13: 2767-2779, 2004. (Pubitemid 39562541)
41. Kaufman Y, Heled M, Perk J, Razin A, Shemer R. Protein-binding elements establish in the oocyte the primary imprint of the Prader-Willi/ Angelman syndromes domain. Proc Natl Acad Sci USA 106: 10242-10247, 2009.
42. Kim DH, Villeneuve LM, Morris KV, Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 13: 793-797, 2006. (Pubitemid 44338773)
43. Kirschmann DA, Lininger RA, Gardner LM, Seftor EA, Odero VA, Ainsztein AM, Earnshaw WC, Wallrath LL, Hendrix MJ. Downregulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res 60: 3359-3363, 2000. (Pubitemid 30482146)
44. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15: 70-73, 1997. (Pubitemid 27014952)
45. Kissel JT. Facioscapulohumeral dystrophy. Semin Neurol 19: 35-43, 1999.
46. Klooster R, Straasheijm K, Shah B, Sowden J, Fronts R, Thornton C, Tawil R, van der Maarel S. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur J Hum Genet 17: 1615-1624, 2009.
47. Korber P, Luckenbach T, Blaschke D, Horz W. Evidence for histone eviction in trans upon induction of the yeast PHO5 promoter. Mol Cell Biol 24: 10965-10974, 2004. (Pubitemid 39603150)
48. Krol J, Fiszer A, Mykowska A, Sobczak K, de Mezer M, Krzyzosiak WJ. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 25: 575-586, 2007. (Pubitemid 46274449)